Literature DB >> 18773055

Development of a swine model of secondary liver tumor from a genetically induced swine fibroblast cell line.

R Abbas1, S J Adam, S Okadal, H Groar, J Anderson, J Sanabria.   

Abstract

AIM: Metastatic disease is the most common liver tumor. Although alternative therapies have been developed for non-surgical candidates, those therapies lacked ideal testing prior to clinical application because of a paucity of large animal models. The purpose of the present study was to develop a model for secondary liver tumor in a large animal.
MATERIAL AND METHODS: Fibroblasts were isolated from swine ear lobules and then transfected with amphotrophic retroviruses encoding human or murine genetic material (hTERT, p53(DD), cyclinD-1, CDK4(R24C), Myc (T58A), Ras(G12V)). Transformed cell lines were finally inoculated subcutaneously (s.c.) into: 1) immunodeficient mice (nude), 2) immunocompetent mice (wild type), 3) immunosuppressed swine (under tacrolimus or corticosteroids), 4) immunocompetent swine, and 5) into the liver and portal circulation of swine under steroid-based immunosuppression.
RESULTS: In the murine model, tumor growth was evident in 100% of the nude mice (n=5), with a peak size of 20 mm (15.22+/-4.5 mm; mean+/-SD) at the time of sacrifice (3 weeks). Tumor growth was evident in 71% of the wild mice (n=21), with a peak size of 7.8 mm (4.19+/-1.1 mm) by the third week of growth. In the swine model, tumor growth was evident in 75% (3/4 ears; n=2) of swine under tacrolimus-based immunosuppression versus 50% of swine under steroids-based immunosuppression (n=2). Tumor growth was slow in two animals, while in one animal the tumor was larger with a peak growth of 42 mm at 3 weeks. The tumor pattern in the ear lobules was characterized by slow growth, with a peak size of 6-8 mm in the immunocompetent swine at 3 weeks. All tumors were shown to be malignant by histology. In contrast, inoculums of the transformed fibroblast cell line in swine livers showed no evidence of tumor growth at 3 weeks.
CONCLUSIONS: Development of a transformed swine fibroblast cell line was successful, resulting in an in vivo malignant tumor. Cell line inoculums had tumorigenic properties in nude mice, wild-type mice, and immunosuppressed swine, as judged by uncontrolled cell growth, invasion of surrounding tissue, neoangiogenesis, and invasion of normal vasculature, resulting in the formation of tumor nodules. Such properties were not observed in swine upon inoculation into the liver/portal circulation.

Entities:  

Keywords:  Cancer models; liver tumors; secondary liver tumors; swine

Year:  2008        PMID: 18773055      PMCID: PMC2504376          DOI: 10.1080/13651820802029435

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  24 in total

1.  Thymocyte apoptosis induced by T cell activation is mediated by glucocorticoids in vivo.

Authors:  Judson A Brewer; Osami Kanagawa; Barry P Sleckman; Louis J Muglia
Journal:  J Immunol       Date:  2002-08-15       Impact factor: 5.422

Review 2.  Hepatic metastases.

Authors:  M R Paley; P R Ros
Journal:  Radiol Clin North Am       Date:  1998-03       Impact factor: 2.303

Review 3.  Liver-directed therapies in colorectal cancer.

Authors:  Daniel T Ruan; Robert S Warren
Journal:  Semin Oncol       Date:  2005-02       Impact factor: 4.929

4.  Nonendoscopic placement and use of percutaneous gastrostomy tubes in pigs (Sus scrofa domestica).

Authors:  N M Gades; T D Mandrell
Journal:  Contemp Top Lab Anim Sci       Date:  2001-03

5.  Genetic induction of tumorigenesis in swine.

Authors:  S J Adam; L A Rund; K N Kuzmuk; J F Zachary; L B Schook; C M Counter
Journal:  Oncogene       Date:  2006-09-11       Impact factor: 9.867

6.  OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer.

Authors:  Graeme J Poston; René Adam; Steven Alberts; Steven Curley; Juan Figueras; Daniel Haller; Francis Kunstlinger; Gilles Mentha; Bernard Nordlinger; Yehuda Patt; John Primrose; Mark Roh; Philippe Rougier; Theo Ruers; Hans Joachim Schmoll; Carlos Valls; Nick Jean-Nicolas Vauthey; Marleen Cornelis; James P Kahan
Journal:  J Clin Oncol       Date:  2005-10-01       Impact factor: 44.544

Review 7.  Immunodominance and tumor escape.

Authors:  H Schreiber; T H Wu; J Nachman; W M Kast
Journal:  Semin Cancer Biol       Date:  2002-02       Impact factor: 15.707

8.  The effect of in vivo hydrocortisone on subpopulations of human lymphocytes.

Authors:  A S Fauci; D C Dale
Journal:  J Clin Invest       Date:  1974-01       Impact factor: 14.808

Review 9.  Economic evaluations of calcineurin inhibitors in renal transplantation: a literature review.

Authors:  Alec H Miners; Guiqing Yao; James Raftery; Rod S Taylor
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

10.  Immune system versus tumor: shifting the balance in favor of DCs and effective immunity.

Authors:  Howard L Kaufman; Mary L Disis
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.